L. Faillace

RadiaBeam Technologies (United States)

Papers

2

Total Citations

33

H-Index

2

About

L. Faillace is a leading figure in the development of compact accelerator technologies for medical and security applications. Their primary research focuses on the design and optimization of novel linear accelerators (linacs) for advanced radiotherapy, with a particular emphasis on enabling highly noncoplanar, robotic treatment delivery. Faillace’s most impactful work, the 2021 paper “Compact X-Band electron linac for radiotherapy and security applications,” has garnered 27 citations, highlighting its significance in advancing portable, high-output radiation sources. This work is foundational for their contributions to the “4π radiotherapy” platform, a novel hardware and software system that facilitates intensity modulated radiotherapy with dramatically reduced normal tissue toxicity and improved tumor dose escalation. By engineering a high-output, compact 3 MV linac, Faillace has addressed a critical bottleneck in robotic radiation delivery, bridging the gap between theoretical treatment planning and practical, clinical implementation. Their achievements represent a crucial step toward more precise, less invasive cancer treatments and versatile security screening tools, establishing them as a key innovator in the intersection of accelerator physics and therapeutic radiology.

Research Focus

Key Achievements

2
H-Index
2
Papers
33
Total Citations
17
Avg Citations/Paper
🏆 Most Cited Paper
Compact X-Band electron linac for radiotherapy and security applications
27 citations · 2021
📈 Most Prolific Year: 2021 (1 Papers)
🤝 Key Collaborators: 17
🏛 Institutions: RadiaBeam Technologies (United States)

Top Papers

  1. 1
  2. 2

Key Collaborators

Contact & Links

Available for collaboration
Content generated · 13 days ago